[ad_1]
There’s yet one more signal that ace Jacob deGrom might finally return to the New York Mets this fall or winter.
Whereas deGrom has repeatedly been linked in tales and rumors with the Texas Rangers and Atlanta Braves, The Athletic’s Ken Rosenthal reported Monday that the Rangers “appear extra assured of touchdown left-hander Carlos Rodon and probably Japanese righty Kodai Senga” than they do of signing the 34-year-old who opted out of his contract earlier this month.
Rosenthal added that the Braves “are solely about $5 million shy of the preliminary $233 million luxury-tax threshold” on the identical time that re-signing deGrom seems to be the Mets’ “focus” this offseason. For a chunk revealed on Nov. 14, Rosenthal stated that the Braves signing deGrom was “extremely unlikely.”
SNY’s Andy Martino reported final week that the New York Yankees had “lately requested medical data on deGrom,” however they’re first concentrating on protecting reigning American League Most Priceless Participant Aaron Choose within the Bronx for the foreseeable future. Rosenthal stated for Monday’s piece {that a} “thriller group” such because the Los Angeles Dodgers might swoop in for deGrom, partially as a result of the Dodgers “relish the kind of short-term, high-dollar deal deGrom is more likely to command.”
It was stated earlier this month that contract predictions indicated big-spending Mets proprietor Steve Cohen would not be outbid for deGrom so long as holding onto the two-time Nationwide League Cy Younger Award winner was a high precedence for the membership.
There are, after all, damage issues concerning the veteran who made solely 26 regular-season begins throughout the previous two campaigns. He handled worrisome elbow points and a stress response within the scapula of his pitching shoulder over that point. Nevertheless, an orthopedic sports activities surgeon believes nothing about these setbacks suggests deGrom’s future damage threat “is increased than every other pitcher of his age.”
[ad_2]
Source link
